Calls for papers
-
Prosonix has announced the appointment of Geoff Down to the newly-created position of Chief Medical Officer, effective immediately. Down, who has extensive experience in clinical development and has served various roles, some as a consultant… Read more . . .
-
According to OptiNose, it filed an investigational new drug (IND) application for an intranasal sumatriptan product with the US FDA in December, 2011, and the FDA has given OptiNose permission to proceed. The company now… Read more . . .
-
Discovery Laboratories has announced that the FDA has approved the Afectair device for marketing in the US, and the company plans a launch later this year. The company describes Afectair as “a proprietary patient interface… Read more . . .
-
Following unprecedented growth in 2011 and to facilitate further growth and leadership succession, Team Consulting is looking to recruit a Commercial Director. You will be responsible for leading the continued profitable growth in sales. This… Read more . . .
-
Team Consulting has announced two new hires: Mark Shepherd, formerly Physical Properties Scientist in respiratory product development at GSK, and Human Factors and User Research Consultant Ben Cox. Shepherd, who has experience with dry powder… Read more . . .
-
California-based Impax Pharmaceuticals has acquired exclusive US rights to several dosage forms of Zomig zolmitriptan, including the nasal spray formulation, from AstraZeneca. Zomig nasal spray is approved in the US for the treatment of migraine… Read more . . .
-
SkyePharma CEO Axel Mueller has resigned “to pursue other interests,” according to the company, and will be replaced by current Chief Financial Officer Peter Grant. The company’s announcement says that Grant, who has been CFO… Read more . . .
-
Contract research organization Melbourn Scientific has announced the promotion of Derek Solomon to Operations Director, effective immediately. Solomon, who joined the company in 2005, previously held the title of Laboratory Manager and oversaw Melbourn’s addition… Read more . . .
-
After having its first offer rejected by ISTA Pharmaceuticals, and after ISTA indicated that an increased offer was still insufficient, Valeant Pharmaceuticals has withdrawn its offer of $7.50 per share a day before its announced… Read more . . .
-
A company called Rapid Fire Marketing says that its subsidiary Medical Cannabis Management is launching a tetrahydrocannabinol (THC) e-cigarette in the US immediately and will follow with a second-generation device in 30-60 days. The device,… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 10: SMI.London 2026, London, UK
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan